Aripiprazole

Aripiprazole

Products
Aripiprazole
Aripiprazole

Information

Therapeutic Area: Nervous SystemEU DMF availableUS DMF no. 23314 availableCEP available Indication: used to treat the symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression). It is also used together with other medications to treat major depressive disorder in adults. Aripirazole is also used to treat irritability and symptoms of aggression, mood swings, temper tantrums, and self-injury related to autistic disorder in children who are at least 6 years old.
Main Categories
APIs (Active Pharmaceutical Ingredients)
All Categories
APIs (Active Pharmaceutical Ingredients)
Distribution areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
Supplied from
Poland
Polpharma SAPolpharma Group is a high quality European pharma manufacturer and a reputable business partner for companies worldwide at every stage of product development, manufacturing & commercialization (FDF, API, CDMO, CMO). Polpharma API is a Poland-based CDMO of APIs, and significant European API producer, delivering products to more than 65 countries on 6 continents. We run with $45-million manufacturing expansion to include HPAPI and cryogenic technologies and investments in a pilot plant and R&D capabilities.

Log in

See all the content and easy-to-use features by logging in or registering!